Yes, our doctors can prescribe all brand-name GLP-1 medications, including Wegovy®, Mounjaro®, and Ozempic®.

Yes. Patients with Type 2 Diabetes or high blood pressure may join the program. However, individuals with the following conditions are not eligible: pancreatitis, active gallbladder disease, diabetic retinopathy, Type 1 Diabetes, macular edema, renal disease, substance abuse, history of medullary thyroid cancer, MEN syndrome, active eating disorders, pregnancy or plans for pregnancy within one year, or breastfeeding.

Contact us immediately so we can notify your doctor. Go to the ER if you experience severe abdominal pain, intractable vomiting or diarrhea, or signs of allergic reaction such as hives, dizziness, fast heartbeat, difficulty breathing, or swelling of the face, lips, tongue, or throat.

Dose increases must be approved by your doctor. Never increase your dose on your own. During your monthly appointment, your provider will evaluate your progress and determine if a dosage change is appropriate.

You will meet with your doctor every month to review your progress, discuss goals, and order your next month of medication.

Yes. Your doctor will guide you through medication usage, dosing, and dietary recommendations to support your weight-loss goals.

All compounded semaglutide and compounded tirzepatide medications are prepared in MFV Pharmacy, a licensed compounding pharmacy based in Utah.

Yes. MFV Pharmacy is fully licensed to compound and dispense medications.

Strength varies by pharmacy. We offer compounded versions that match brand-name strengths, as well as alternative strengths.

Shipping typically takes 2–4 business days.

Yes. GLP-1 medications must be refrigerated.

If your package is delayed beyond 2–4 business days, contact us. Compounded GLP-1 medications can remain warm for up to 3 days. Refrigerate as soon as possible upon arrival or call us for guidance.

You must meet with your doctor each month to receive your next prescription.

The pharmacy ships to most states except Alaska, Arkansas, and Maine. California shipping depends on medication type.

No. Lab pricing depends on the lab company you choose.

No. We do not accept insurance and cannot submit claims for insurance reimbursement.

You may cancel your appointment at any time. Medication orders cannot be refunded once they are placed by the doctor.

Yes. All platforms used are HIPAA compliant, and our staff is trained in HIPAA privacy and security standards.

Yes. A valid, up-to-date state ID or driver’s license is required for the doctor to prescribe medication.

Compounded medications cannot be transferred. Some brand-name prescriptions may be filled at a local retail pharmacy depending on the medication.

Compounded GLP-1s are customized by compounding pharmacies. They contain the same active ingredient but are not FDA-approved like Wegovy®, Ozempic®, or Mounjaro®.

Semaglutide works on the GLP-1 receptor only, while tirzepatide targets both GLP-1 and GIP receptors. Tirzepatide often produces faster and greater weight loss, though both are effective and safe.

No. Compounded GLP-1 medications are not FDA-approved but are permitted when prepared by licensed compounding pharmacies to meet clinical needs or drug shortages.

Possibly. Some combinations are safe, while others should be avoided. Your provider will review your medications and determine if GLP-1 therapy is appropriate.

Individuals with a history of medullary thyroid cancer, MEN2, pancreatitis, severe GI disorders, or certain medication interactions may not be eligible. Your provider will evaluate your medical history to determine if you are a candidate.

Compounded medications are not commercially manufactured or FDA-approved, allowing pharmacies to make them at lower cost, creating a more affordable option for many patients.

GLP-1 medications are injected subcutaneously into the abdomen, thigh, or upper arm. Your care team will provide instructions for safe self-administration.

Most patients feel little to no discomfort. The needle is very small, and rotating injection sites helps minimize irritation.

Yes. Keep medication refrigerated as directed and carry it in your hand luggage with your prescription label when flying.

Take the missed dose as soon as you remember unless it is close to your next scheduled dose. Do not double-dose. Contact your provider if unsure.

Dispose of used needles in a sharps container or a thick, puncture-proof container. Follow local disposal guidelines or use a designated drop-off site.

A specific plan isn’t required, but combining GLP-1 therapy with balanced nutrition and regular exercise significantly improves results.

Many patients notice reduced appetite within the first week. Appetite suppression typically increases as your dose gradually rises.

Weight regain is possible after stopping the medication, especially without consistent diet and exercise habits. Long-term lifestyle changes are key to maintaining results.

Yes. GLP-1 therapy is safe for long-term use when monitored by a provider. Many patients remain on treatment to maintain weight loss and metabolic benefits.

Depression is not a common side effect. Some individuals may experience temporary mood changes when starting treatment. Contact your provider if symptoms persist.

Pancreatitis is a rare but serious potential side effect. Seek emergency care if you experience severe abdominal pain, nausea, or vomiting.

GLP-1 medications do not directly cause hair loss. Rapid weight loss may trigger temporary shedding, which usually resolves as weight stabilizes.

Yes. Headaches can occur early in treatment. Staying hydrated and eating regularly often helps alleviate symptoms.

Yes. Oral semaglutide (Rybelsus®) is available. However, injectable GLP-1 medications typically deliver stronger weight-loss results.

Anxiety is not a typical side effect, though some patients may experience temporary restlessness when adjusting to the medication.

Most patients qualify based on BMI and medical history. GLP-1 medications are typically prescribed for individuals with:

• BMI of 30 or higher, or
• BMI of 27 or higher with a related condition, such as high blood pressure, Type 2 diabetes, elevated cholesterol, or other metabolic concerns.

Your provider will review your full health history to determine eligibility, even if your BMI is below these thresholds.

The FDA-approved GLP-1 medications for weight loss are Semaglutide 2.4 mg (Wegovy®) and Tirzepatide (Zepbound®). Compounded versions are not FDA-approved.